Dr. Rippee speaks about enrolling patients in Oxeia’s Phase 2 Clinical Trial for Concussions on KU’s Morning Medical Update
Dr. Michael Rippee, Medical Director for the Center for Concussion Management and a Sports Neurologist at the University of Kansas Medical Center, talks about enrolling participants and the exciting science behind Oxeia’s Phase 2 Concussion Trial.